T.S. ELLIS, III, District Judge.
At issue on cross motions for summary judgment in this action seeking review of a decision from the Patent and Trademark Office's ("PTO") Trial and Appeal Board ("TTAB") is whether the TTAB erred in denying registration for the term "PROBIOTIC" on the grounds that the term is generic in connection with fertilizer, and alternatively, that the term at best is descriptive and has not acquired secondary meaning. For the reasons that follow, the TTAB did not err in denying registration to plaintiff. Accordingly, plaintiffs motion for summary judgment must be denied, and defendant's motion for summary judgment must be granted.
Plaintiff Milo Shammas, the sole owner of Dr. Earth, Inc., filed a federal trademark application on June 12, 2009 for the term PROBIOTIC in connection with fertilizer. In an Office Action on September
In affirming the Examining Attorney's denial, the TTAB found that the term was merely generic, stating that "competitors' use of the term `Probiotics' as the technology behind their products is persuasive evidence that the relevant consumers perceive the term as generic ... and that competitors need to use the term." In re Milo Shammas, No. 77758863 at 13. In support of this finding, the TTAB noted that "articles about soil treatment identify probiotics as ... the technology or method of using friendly bacteria on the soil as an ingredient of fertilizer." Id. Thus, the TTAB concluded that "the relevant consumers are going to understand PROBIOTIC as the genus of goods, namely a fertilizer utilizing probiotic technology." Id. at 16.
Alternatively, the TTAB also found that the term PROBIOTIC, even if descriptive, has not acquired secondary meaning. In reaching this result, the TTAB noted that plaintiff "did not submit any sales figures, either in dollar or units, market share information, or advertising expenditures" to support any finding of distinctiveness. Id. at 18. The TTAB also noted that "the record is lacking in any media recognition regarding applicant's product and how the term PROBIOTIC points uniquely and exclusively to applicant." Id.
Thereafter, on December 19, 2012, Plaintiff filed this action seeking review of the TTAB's decision pursuant to 15 U.S.C. § 1071(b)(1), arguing that the TTAB erred in finding that the term PROBIOTIC is generic, and alternatively, that the term, even if descriptive, has not acquired secondary meaning. Plaintiff seeks (1) reversal of the TTAB's decision, (2) a declaration that the term PROBIOTIC is suggestive or, alternatively, that it merits registration as a distinctive trademark that has acquired secondary meaning, and (3) any other relief deemed proper.
The parties have filed cross motions for summary judgment that essentially present the following two questions: (1) whether the TTAB erred in finding that the term PROBIOTIC is generic for fertilizer, and (2) whether the TTAB erred in finding, alternatively, that the term PROBIOTIC, even if descriptive, has not acquired secondary meaning.
The summary judgment standard is too well-settled to merit extended discussion, nor do the parties dispute this standard. Summary judgment should not be granted when the non-moving party has "set forth specific facts showing that there is a genuine issue for trial" through "affidavits or as otherwise provided." Fed. Rules Civ. P. 56. A genuine factual dispute exists "if the evidence is such that a reasonable jury could return a verdict for the nonmoving
Plaintiff has filed this action under 15 U.S.C. § 1071, which allows trademark applicants dissatisfied with the TTAB's decision either to appeal to the Court of Appeals for the Federal Circuit or to file an action in district court. Where, as here, the plaintiff files an action in the district court, the district court "`sits in a dual capacity,' serving on one hand as the finder of fact with respect to new evidence presented by the parties, and on the other as an appellate reviewer of facts found by the TTAB." Glendale Intern. Corp. v. U.S. Patent & Trademark Office, 374 F.Supp.2d 479, 485 (E.D.Va.2005).
When acting as an appellate reviewer in an action under § 1071(b), a district court reviews the TTAB's findings of fact deferentially and must uphold those findings of fact if they are supported by "substantial evidence" under the Administrative Procedure Act ("APA").
"Substantial evidence," as stated by the Supreme Court, is "more than a mere scintilla of evidence" and requires "such relevant evidence as a reasonable mind would accept as adequate to support a conclusion." In re Pacer Technology, 338 F.3d 1348, 1349 (Fed.Cir.2003) (quoting Consol. Edison v. N.L.R.B., 305 U.S. 197, 229, 59 S.Ct. 206, 83 L.Ed. 126 (1938)). As the Federal Circuit has noted, "a review for substantial evidence `involves examination of the record as a whole, taking into account evidence that both justifies and detracts from an agency's decisions.'" On-Line Careline, 229 F.3d at 1086 (quoting Universal Camera Corp. v. N.L.R.B., 340 U.S. 474, 487-88, 71 S.Ct. 456, 95 L.Ed. 456 (1951)). A finding of fact by the TTAB will not be "upset unless it is not supported by substantial evidence." McCarthy on Trademark, § 21:21. Moreover, "the possibility of drawing two inconsistent conclusions from the evidence does not prevent an administrative agency's finding from being supported by substantial evidence." Id. (quoting Consolo v. Federal Maritime Comm'n, 383 U.S. 607, 620, 86 S.Ct. 1018, 16 L.Ed.2d 131 (1966)). As stated by the Federal Circuit, the TTAB's decision "may not be reversed ... even if [the reviewing court] would have viewed the facts differently if sitting as the tribunal of original jurisdiction," so long as substantial evidence supports the TTAB's ruling. If the evidence before the TTAB supports two conclusions, "the Board's decision to favor one over the other ... must be sustained ... as supported by substantial evidence." DuoProSS Meditech Corp. 695 F.3d at 1252.
Accordingly, the analysis in this case proceeds as follows: first, the TTAB's findings of fact — the TTAB's conclusion that the term PROBIOTIC is generic, and alternatively, lacks secondary meaning — must be reviewed deferentially pursuant to the substantial evidence standard. Next, the new evidence submitted by the parties must be reviewed de novo to determine what findings of fact are warranted by this new evidence. Finally, in the event that the new evidence warrants findings that contradict, or are inconsistent with, the TTAB's factual findings supported by substantial evidence, the district court must then consider whether the record as a whole establishes that plaintiff has borne his burden of proving by a preponderance of the evidence that the term PROBIOTIC is a protectable mark.
The essential facts found by the TTAB are as follows:
A review of the record before the TTAB reveals that each of these findings of fact is amply supported by substantial evidence.
First, the TTAB found that the genus of goods at issue is fertilizer. As the TTAB pointed out, the parties do not dispute this fact. In re Milo Shammas, No. 77758863 at 4.
Second, the TTAB found that the relevant public, when it considers PROBIOTIC in connection with fertilizer, readily understands the term to identify a type of fertilizer, and therefore, that "the relevant consumers perceive the term as generic." Id. at 13. In reaching this conclusion, the TTAB relied on several sources. For example, the TTAB cited to the fact that at least eight of Dr. Earth's competitors use the term "probiotic" to describe an aspect or feature of their fertilizer and soil products.
But the TTAB did not end its analysis at this point, as it might have
This does not end the analysis. Because the plaintiff has chosen to sue in district court, rather than appeal to the Federal Circuit, the parties have the opportunity to introduce new evidence here not considered by the TTAB.
With regard to the generic nature of a proposed mark, the Fourth Circuit has stated that a generic name "merely employs the common name of a product or service or refers to the genus of which the particular product is a species." Retail Services, Inc. v. Freebies Publishing, 364 F.3d 535, 538 (4th Cir.2004) (citing Two Pesos, Inc. v. Taco Cabana, Inc., 505 U.S. 763, 768, 112 S.Ct. 2753, 120 L.Ed.2d 615 (1992). A generic name "is the name of a product or service itself — what it is." McCarthy on Trademark, § 12:1. In essence, this means that if the term PROBIOTIC answers the question "what are you," it is a generic term because it tells the buyer what the product is, not the source of the product. Id. Conversely, if the term PROBIOTIC answers the question "who are you" or "where do you come from," it is not a generic term because it tells the buyer the source of the product, not the nature of the product. Id. Accordingly, a generic term, which merely identifies the nature of the product, is the antithesis of a distinctive term and cannot be protected as a trademark or registered as one. See Sara Lee Corp. v. Kayser-Roth Corp., 81 F.3d 455, 464 (4th Cir.1996); Park `N Fly, Inc. v. Dollar Park & Fly, Inc., 469 U.S. 189, 194, 105 S.Ct. 658, 83 L.Ed.2d 582 (1985)).
As the Federal Circuit has stated,
According to the Federal Circuit, a finding of genericness involves a two-step inquiry. First, a court must identify the "genus of goods or services at issue." H. Marvin Ginn Corp. at 990. Second, a court must determine whether "the term sought to be registered ... [is] understood by the relevant public primarily to refer to that genus of goods or services." Id. Here, the TTAB established, and the parties do not dispute, that the "genus of goods at issue in this case is adequately defined by the description of goods — fertilizer." In re Milo Shammas, No. 77758863 at 4. Thus, the only disputed issue on the genericness issue is whether purchasers of fertilizers understand the term PROBIOTIC as referring on one hand to fertilizer or a distinctive characteristic of fertilizers, or on the other hand to plaintiffs product specifically.
Here, both plaintiff and defendant have offered new evidence on the issue of the relevant public's understanding
Thus, the plaintiffs evidence pertinent to genericness, in the end, consists only of the testimony of three of Dr. Earth's retailers stating that they are unaware of any other producers of organic fertilizers who also use the term "probiotic" to describe their fertilizer and soil products.
Nor is this a complete summary of the evidence on the genericness issue, as defendant has offered new, additional evidence on the issue as follows:
The five additional sources submitted by defendant are strong evidence the term PROBIOTIC, in the minds of purchasers of fertilizer, describes fertilizers or a distinctive characteristic of fertilizers.
In summary, the record as a whole — the parties' newly-submitted evidence and the record before the TTAB — points convincingly to the conclusion that the term PROBIOTIC is generic. Put another way, a review of the entire record discloses that plaintiff has failed to adduce evidence that would permit a finder of fact to conclude, by a preponderance of the evidence, that the term PROBIOTIC is something other than a generic term ineligible for trademark protection.
A finding that a term is generic necessarily precludes a finding that the term is descriptive with secondary meaning. As noted, if a term is generic, it cannot have the type of consumer recognition necessary for a finding of acquired secondary meaning. See McCarthy on Trademark, § 12:46. Because secondary meaning denotes evidence of trademark usage by some majority of relevant customers, "if the consuming public does perceive the symbol as designating the producer rather than the product, then the generic label has been incorrectly applied." Id. (quoting Miller Brewing Co. v. Falstaff Brewing Corp., 503 F.Supp. 896, 907-908 (D.R.I.1980)). Thus, assuming, arguendo, that the TTAB erred in finding PROBIOTIC generic in connection with fertilizer, plaintiff has also submitted new evidence to support his assertion that PROBIOTIC is descriptive with secondary meaning in connection with fertilizer and should thus be given trademark protection.
Secondary meaning is "a new and additional meaning that attaches to a non-inherently distinctive word," such as a descriptive word.
Importantly, proof of secondary meaning "entails vigorous evidentiary requirements." Id. Evidence for such a claim may include direct evidence, such as customer surveys, or circumstantial evidence, such as input of the seller, evidence of sales volume, length of time used, and quantity and quality of the advertising and promotion. McCarthy on Trademarks, § 15:1. The most direct, and likely most expensive, means of showing secondary meaning is a rigorously conducted customer survey that is fully consistent with statistical sampling methodology.
An analysis of the record evidence on secondary meaning properly begins by recalling that the TTAB, in concluding that the term PROBIOTIC has not acquired distinctiveness, noted that "applicant did not submit any sales figures ... market share information, or advertising expenditures," nor did applicant submit "any media recognition regarding applicant's product and how the term PROBIOTIC points uniquely and exclusively to applicant." In re Milo Shammas, No. 77758863 at 18. Now, plaintiff has attempted to remedy that lack of evidence before the TTAB by relying on the following newly submitted material:
To be sure, evidence of sales volume, market share, and advertising expenditures may, if reliably and contextually established, have some probative value to show, circumstantially, the existence of secondary meaning. Yet, plaintiffs submissions on these topics fall far short of doing so; they fail to meet the "vigorous evidentiary requirements" necessary to show that there is a link in the minds of relevant consumers between the term PROBIOTIC and a single source of organic fertilizer containing microbes and mycorrhizae. Perini Corp., 915 F.2d at 125. This is especially apparent when the administrative record and the parties' submissions are taken into account.
To begin with, plaintiffs 74 million dollars in total sales of fertilizer products over the past twelve years — roughly six million dollars per year — has little, if any, probative value on the issue of secondary meaning, as there is no clear information concerning whether these sales constitute a significant share of the national market for organic fertilizers containing microbes and mycorrhizae. Nor is this deficiency remedied by plaintiffs claim that his sales of Dr. Earth fertilizer, along with the sales of six other sellers of organic fertilizers (who do not use the term probiotic) account for between 80 and 90 percent of the market for organic fertilizers containing microbes and mycorrhizae. There are two problems with such evidence. First, it is unclear whether plaintiffs sales are a substantial or insubstantial part of the 80 to 90 percent of the claimed market share. If plaintiffs market share is relatively small, then his evidence of sales, revenue, and market share would have little, if any, probative value on the existence of secondary meaning. The second problem is that plaintiffs statement flies in the face of record evidence of as many as thirty-two producers of organic fertilizer using the term "probiotic" to describe their product — eight producers relied on by the TTAB, and twenty-five more producers submitted by defendant in this action.
Similarly, plaintiffs advertising expenditures do little to advance the cause of establishing secondary meaning. As Professor McCarthy has noted, "mere expenditure of money [on advertising] is not, in itself, determinative of the actual result in buyers' minds."
Finally, plaintiff has submitted affidavits from three retailers of Dr. Earth products, all of whom state that they are unaware of any other sellers in the organic fertilizer market using the term "probiotic" for their fertilizer products. As noted previously, these affidavits are unpersuasive because they merely attest to and establish the retailer's unawareness of a fact, and therefore fall short of contradicting the evidence establishing the fact. Moreover, as Professor McCarthy has noted, conclusory "opinion evidence" from friendly retailers is often biased and "does not necessarily reflect the view of the consumer class." McCarthy on Trademark, § 15:39.
In sum, plaintiffs submissions on product sales, market share, advertising expenditures, and seller affidavits are collectively insufficient to satisfy plaintiffs burden to show the existence of secondary meaning. Plaintiffs submissions also fail to cast doubt both (i) on the TTAB's finding — supported by substantial evidence on the administrative record — that PROBIOTIC is generic, and (ii) on the result reached here that the record as a whole shows convincingly that the term is generic. Because defendant is entitled to judgment as a matter of law with respect to the genericness issue, it is unnecessary
An appropriate Order will issue.
Nor is it necessary to reach the issue of whether a jury trial is appropriate in a § 1071(b) case, as neither party requested a jury in this case. See Har-Bur Associates v. Docktor Pet Centers, Inc., 678 F.Supp. 98 (E.D.Pa.1986) (stating that the type of "mixed" review in a § 1071(b) action is "not compatible with the determination of fact issues by a jury," because in a jury trial, the jury does not perform an appellate of reviewing function as to previously decided issues); Millers' Mut. Ins. Ass'n. of Illinois v. Quigg, 1987 WL 39928 (S.D.Ill.1987). But see Material Supply Intern., Inc. v. Sunmatch Indus. Co. Ltd., 146 F.3d 983 (D.C.Cir.1998) (stating that a district court judge must first allow the jury to decide factual issues, after which the court should decide the appeal from the Board decision).